1. Home
  2. COCP vs DFLI Comparison

COCP vs DFLI Comparison

Compare COCP & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • DFLI
  • Stock Information
  • Founded
  • COCP 2006
  • DFLI 2020
  • Country
  • COCP United States
  • DFLI United States
  • Employees
  • COCP N/A
  • DFLI N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • COCP Health Care
  • DFLI Technology
  • Exchange
  • COCP Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • COCP 15.4M
  • DFLI 14.5M
  • IPO Year
  • COCP N/A
  • DFLI N/A
  • Fundamental
  • Price
  • COCP $1.07
  • DFLI $0.87
  • Analyst Decision
  • COCP Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • COCP 1
  • DFLI 1
  • Target Price
  • COCP $6.00
  • DFLI $1.50
  • AVG Volume (30 Days)
  • COCP 197.1K
  • DFLI 32.5M
  • Earning Date
  • COCP 11-14-2025
  • DFLI 11-14-2025
  • Dividend Yield
  • COCP N/A
  • DFLI N/A
  • EPS Growth
  • COCP N/A
  • DFLI N/A
  • EPS
  • COCP N/A
  • DFLI N/A
  • Revenue
  • COCP N/A
  • DFLI $54,536,000.00
  • Revenue This Year
  • COCP N/A
  • DFLI $27.77
  • Revenue Next Year
  • COCP N/A
  • DFLI $42.02
  • P/E Ratio
  • COCP N/A
  • DFLI N/A
  • Revenue Growth
  • COCP N/A
  • DFLI 4.80
  • 52 Week Low
  • COCP $1.00
  • DFLI $0.15
  • 52 Week High
  • COCP $3.26
  • DFLI $4.99
  • Technical
  • Relative Strength Index (RSI)
  • COCP 43.45
  • DFLI 43.80
  • Support Level
  • COCP $1.06
  • DFLI $1.04
  • Resistance Level
  • COCP $1.15
  • DFLI $1.12
  • Average True Range (ATR)
  • COCP 0.07
  • DFLI 0.15
  • MACD
  • COCP 0.01
  • DFLI -0.07
  • Stochastic Oscillator
  • COCP 23.54
  • DFLI 14.98

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.

Share on Social Networks: